![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
20
Kern Pharma, S.l. Terrassa Es, based in Spain, is a pharmaceutical company.
One of their significant offerings is Alfentanil hydrochloride hydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2013-139 - Rev 00
This Chemical Type CEP, issued on January 16, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1062 associated with this CEP further emphasizes